• Lourdes G Planas, Kimberly M Crosby, Kevin C Farmer, and Donald L Harrison.
• College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, USA.
• J Am Pharm Assoc (2003). 2012 Jan 1; 52 (6): e130-8.

ObjectiveTo evaluate the efficacy of a community-based, pharmacist-directed diabetes management program among managed care organization enrollees using National Committee for Quality Assurance (NCQA)-Healthcare Effectiveness Data and Information Set (HEDIS) performance measures.DesignRandomized controlled trial.SettingRegional community pharmacy chain in Tulsa, OK, from November 2005 to July 2007.Patients52 participants with diabetes and hypertension who were enrolled in a managed care organization.InterventionDiabetes management versus standard care.Main Outcome MeasuresComprehensive diabetes care measures of glycosylated hemoglobin (A1C <7.0%), blood pressure (<130/80 mm Hg), and low-density lipoprotein (LDL) cholesterol (<100 mg/dL). A composite research outcome of success was created by determining whether a participant achieved two of the three HEDIS goals at the end of 9 months.Results46.7% of intervention group participants achieved the A1C goal, while 9.1% of control group participants achieved the goal ( P < 0.002). More than one-half (53.3%) of intervention participants achieved the blood pressure goal compared with 22.7% of control participants ( P < 0.02). Among control group participants, 50% achieved the LDL cholesterol goal compared with 46.67% of intervention group participants. The odds of the intervention group attaining the composite goal were 5.87 times greater than the control group.ConclusionA community pharmacy-based diabetes management program was effective in achieving A1C and blood pressure goals measured by NCQA-HEDIS performance standards. Program participants were statistically significantly more likely to achieve two of three HEDIS standards during a 9-month period.

31 keywords...

hide…